Scleroderma Lung Study Ii: Comparison Of Therapy With Mycophenolate Mofetil Versus Oral Cyclophosphamide In Patients With Symptomatic Scleroderma Interstitial Lung Disease

被引：0
|
作者：
Tashkin, D. P. [1 ]
Roth, M. D. [1 ]
Furst, D. E. [1 ]
Clements, P. [1 ]
Khanna, D. [2 ]
Volkmann, E. [1 ]
Kalafa, S. [1 ]
Goldin, J. [3 ]
Kim, G. H. J. [3 ]
Arriola, E. [4 ]
Tseng, C. -H. [4 ]
Elashoff, R. E. [4 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI USA
[3] David Gefen Sch IMed, Los Angeles, CA USA
[4] David Geffen Sch Med, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6432
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
    Tashkin, Donald P.
    Roth, Michael D.
    Clements, Philip J.
    Furst, Daniel E.
    Khanna, Dinesh
    Kleerup, Eric C.
    Goldin, Jonathan
    Arriola, Edgar
    Volkmann, Elizabeth R.
    Kafaja, Suzanne
    Silver, Richard
    Steen, Virginia
    Strange, Charlie
    Wise, Robert
    Wigley, Fredrick
    Mayes, Maureen
    Riley, David J.
    Hussain, Sabiha
    Assassi, Shervin
    Hsu, Vivien M.
    Patel, Bela
    Phillips, Kristine
    Martinez, Fernando
    Golden, Jeffrey
    Connolly, M. Kari
    Varga, John
    Dematte, Jane
    Hinchcliff, Monique E.
    Fischer, Aryeh
    Swigris, Jeffrey
    Meehan, Richard
    Theodore, Arthur
    Simms, Robert
    Volkov, Suncica
    Schraufnagel, Dean E.
    Scholand, Mary Beth
    Frech, Tracy
    Molitor, Jerry A.
    Highland, Kristin
    Read, Charles A.
    Fritzler, Marvin J.
    Kim, Grace Hyun J.
    Tseng, Chi-Hong
    Elashoff, Robert M.
    LANCET RESPIRATORY MEDICINE, 2016, 4 (09): : 708 - 719
  • [22] Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Sim, Myung
    Li, Ning
    Khanna, Dinesh
    Roth, Michael D.
    Clements, Philip J.
    Hoffmann-Vold, Anna-Maria
    Furst, Daniel E.
    Kim, Grace
    Goldin, Jonathan
    Elashoff, Robert M.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1316 - 1325
  • [23] IMMUNOSUPPRESSANTS (CYCLOPHOSPHAMIDE AND MYCOPHENOLATE MOFETIL) VERSUS RITUXIMAB A SINGLE-AGENT THERAPY IN SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE: REAL CLINICAL PRACTICE
    Koneva, O.
    Ananyeva, L. P.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 683 - 683
  • [24] Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
    Baqir, Misbah
    Makol, Ashima
    Osborn, Thomas G.
    Bartholmai, Brian J.
    Ryu, Jay H.
    PLOS ONE, 2017, 12 (05):
  • [25] Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
    Gerbino, Anthony J.
    Goss, Christopher H.
    Molitor, Jernj A.
    CHEST, 2008, 133 (02) : 455 - 460
  • [26] CYCLOPHOSPHAMIDE VS MYCOPHENOLATE MOFETIL IN SCLERODERMA INTERSTITIAL LUNG DISEASE (SSC-ILD) AS INDUCTION THERAPY: A SINGLE CENTER, RETROSPECTIVE ANALYSIS
    Bavliya, M. K.
    Shenoy, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1115 - 1115
  • [27] Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease Findings From the Scleroderma Lung Study
    Theodore, Arthur C.
    Tseng, Chi-Hong
    Li, Ning
    Elashoff, Robert M.
    Tashkin, Donald P.
    CHEST, 2012, 142 (03) : 614 - 621
  • [28] Cyclophosphamide versus placebo in scleroderma lung disease
    Tashkin, Donald P.
    Elashoff, Robert
    Clements, Philip J.
    Goldin, Jonathan
    Roth, Michael D.
    Furst, Daniel E.
    Arriola, Edgar
    Silver, Richard
    Strange, Charlie
    Bolster, Marcy
    Seibold, James R.
    Riley, David J.
    Hsu, Vivien M.
    Varga, John
    Schraufnagel, Dean E.
    Theodore, Arthur
    Simms, Robert
    Wise, Robert
    Wigley, Fredrick
    White, Barbara
    Steen, Virginia
    Read, Charles
    Mayes, Maureen
    Parsley, Ed
    Mubarak, Kamal
    Connolly, M. Kari
    Golden, Jeffrey
    Olman, Mitchell
    Fessler, Barri
    Rothfield, Naomi
    Metersky, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (25): : 2655 - 2666
  • [29] Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post-Hoc Analyses from the Scleroderma Lung Study I and II
    Namas, Rajaie
    Tashkin, Donald P.
    Wilhalme, Holly
    Furst, Daniel E.
    Tseng, Chi-hong
    Roth, Michael
    Kafaja, Suzanne
    Volkmann, Elizabeth R.
    Clements, Philip J.
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] Improved lung function in patients with scleroderma and interstitial disease with the use of cyclophosphamide
    Dellaripa, PF
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (01) : 51 - 52
12345